Skip to main content

Table 4 Primary Outcomes classified by Dimension and Domain: Composite Efficacy Outcome Dataset

From: Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis

Dimension

Domain

Number (n/35)

Percentage (%)

Activity

All

32

91

 

AC cells

21

60

 

Vitreous haze

30

86

 

Vitreous cells

2

6

 

Snowballs

1

3

 

Macular Oedema

4

11

 

Chorioretinal inflammatory lesions

5

14

 

Retinovascular inflammation

7

20

 

Treatment requirement

10

29

Damage/Other complications of disease

All

0

0

Visual function (performance)

All

22

63

 

Visual acuity

22

63

Visual function (patient reported)

All

0

0

Unspecified

 

3

9